Which technological advancements can we expect to see in the field of medical technology? How well can diagnosis and therapy be customized for each patient? And how much automation can medicine handle?
To help answer these fundamental questions, the Fraunhofer MEVIS Institute for Medical Image Computing will hold a symposium entitled “Disruptive Innovations in Medicine” on September 4, 2013 at Jacobs University in Bremen. The occasion for the symposium is the farewell of Prof. Heinz-Otto Peitgen, founder and long-time institute director of Fraunhofer MEVIS.
Medical science is at a point of transition. Established diagnostic methods such as ultrasound, X-ray, and MRI are continually being improved. These methods can now deliver extremely detailed imagery and information. In addition, new methods are constantly being developed, including the combination of MRI and PET scans for cancer diagnosis. At the same time, the spectrum of therapy options is always growing: new medications for specific patient groups are now being marketed. Operating room methods are becoming more refined, and the number of minimally invasive intervention options is ever expanding.
However, these advancements carry enormous demands and these new options increase complexity. Next-generation CT and MRI deliver images with data size many times those made by older devices. In addition, a current trend is to combine the images and information from many different methods to obtain more reliable diagnoses. This results in a true flood of various image data. “These data gluts reach the limits of what even specialized clinicians can absorb in their daily routine,” says MEVIS institute director Horst Hahn. “Often, they are barely able to incorporate all available information into their therapy decisions.”
In the future, computers could offer useful support. Researchers have already developed programs to employ patterns to search lung and breast x-rays, helping doctors during early detection of cancer. Preliminary studies have shown that the abilities of computers using pattern recognition often match those of humans, or, as in the case of suspected microcalcification in mammography, exceed them.
There are still outstanding problems to solve in computer-aided diagnosis (CAD), such as the number of false alarms. Experts also estimate that the growing amount of data will not be able to be handled without the use of intelligent diagnosis software. “We are not seeking to replace doctors with machines, but rather to create an optimal team of both humans and computers,” said Hahn. “Computers and humans feature contrasting strengths and weaknesses, requiring us to think broadly about how much automation is reasonable for medicine.”
A further focus of the symposium is ‘personalized medicine.’ Until now, this has meant using genetic testing to find out whether a patient could benefit from a certain medication. However, it is now becoming clear that diagnostic methods can be customized for individual patients or certain symptoms, as seen in positron emission tomography (PET), a highly sensitive method used in tumor detection. To mark tumor cells, only a small amount of 'tracers' are presently used.
In laboratories, experts have already developed a number of tracers, although these must still pass extensive approval procedures. This growing array of options is also available in other fields of image-based diagnosis. However, these stand in opposition to the efforts of medicine to verify every new method based on large, randomized studies. "Thus, we must thoroughly reflect upon a responsible approach towards the quickly growing spectrum of diagnostic and therapeutic options and which roles computer support could play," said Hahn.
Finally, the session will tackle new and revolutionary therapeutic approaches for radiotherapy and particle therapy, among others. The novel term 'theranostics' is now being used to describe the close relationship between diagnosis and therapy in a combined, patient-specific approach. An even newer method directly links ultrasound diagnosis and therapy. Using this method, clinicians administer a special ultrasound contrast medium to the patient to record imaging of an organ, such as the kidney. The contrast medium serves not only to help depict tumor tissue, but also to deliver the medication.
The moment an image shows an abscess, the clinician could use a focused ultrasound signal to burst the microscopic bubbles that make up the contrast medium. This would discharge the medication that immediately surrounds the tumor, providing organ-preserving therapy with few side effects. "These new types of therapy are very promising," said Hahn, "but we must thoroughly investigate each new method to determine whether their benefits truly affect the clinical routine and whether they are economically feasible."
On the day following the symposium, the event will move to the MEVIS's institute facilities. Interactive demonstrations by MEVIS researchers will clearly demonstrate how the computer support of the future could take shape for fields such as breast cancer, lung, and stroke diagnosis as well as navigated, minimally invasive tumor therapy. A further demonstration will feature a new tablet app to support liver operations. In August, this app was tested for the first time during an operation in Germany. Media representatives are welcome to attend.September 4: Symposium - "Disruptive Innovations in Medicine" at Jacobs University.
September 5: Open House at Fraunhofer MEVIS, 9 to 13:30. Visitors are very welcome to attend.
Bianka Hofmann | idw
#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017
14.10.2016 | GESIS - Leibniz-Institut für Sozialwissenschaften
Agricultural Trade Developments and Potentials in Central Asia and the South Caucasus
14.10.2016 | Leibniz-Institut für Agrarentwicklung in Transformationsökonomien (IAMO)
Researchers from the Institute for Quantum Computing (IQC) at the University of Waterloo led the development of a new extensible wiring technique capable of controlling superconducting quantum bits, representing a significant step towards to the realization of a scalable quantum computer.
"The quantum socket is a wiring method that uses three-dimensional wires based on spring-loaded pins to address individual qubits," said Jeremy Béjanin, a PhD...
In a paper in Scientific Reports, a research team at Worcester Polytechnic Institute describes a novel light-activated phenomenon that could become the basis for applications as diverse as microscopic robotic grippers and more efficient solar cells.
A research team at Worcester Polytechnic Institute (WPI) has developed a revolutionary, light-activated semiconductor nanocomposite material that can be used...
By forcefully embedding two silicon atoms in a diamond matrix, Sandia researchers have demonstrated for the first time on a single chip all the components needed to create a quantum bridge to link quantum computers together.
"People have already built small quantum computers," says Sandia researcher Ryan Camacho. "Maybe the first useful one won't be a single giant quantum computer...
COMPAMED has become the leading international marketplace for suppliers of medical manufacturing. The trade fair, which takes place every November and is co-located to MEDICA in Dusseldorf, has been steadily growing over the past years and shows that medical technology remains a rapidly growing market.
In 2016, the joint pavilion by the IVAM Microtechnology Network, the Product Market “High-tech for Medical Devices”, will be located in Hall 8a again and will...
'Ferroelectric' materials can switch between different states of electrical polarization in response to an external electric field. This flexibility means they show promise for many applications, for example in electronic devices and computer memory. Current ferroelectric materials are highly valued for their thermal and chemical stability and rapid electro-mechanical responses, but creating a material that is scalable down to the tiny sizes needed for technologies like silicon-based semiconductors (Si-based CMOS) has proven challenging.
Now, Hiroshi Funakubo and co-workers at the Tokyo Institute of Technology, in collaboration with researchers across Japan, have conducted experiments to...
14.10.2016 | Event News
14.10.2016 | Event News
12.10.2016 | Event News
21.10.2016 | Health and Medicine
21.10.2016 | Information Technology
21.10.2016 | Materials Sciences